Ocular Therapeutix's Total Assets for the quarter that ended in Mar. 2024 was $538.95 Mil.
During the past 12 months, Ocular Therapeutix's average Total Assets Growth Rate was 13.10% per year.
During the past 3 years, the average Total Assets Growth Rate was 18.50% per year.
During the past 5 years, the average Total Assets Growth Rate was 24.20% per year.
During the past 10 years, the average Total Assets Growth Rate was 41.40% per year.
During the past 12 years, Ocular Therapeutix's highest 3-Year average Total Assets Growth Rate was 60.60%. The lowest was 18.50%. And the median was 52.90%.
The historical data trend for Ocular Therapeutix's Total Assets can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
From the capital sources of the assets, some of the assets are funded through shareholder's paid in capital and retained earnings of the business. Others are funded through borrowed money.
Ocular Therapeutix's Total Assets for the fiscal year that ended in Dec. 2023 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Ocular Therapeutix (NAS:OCUL) Total Assets Explanation
Note:
The Net Income data used here is four times the quarterly (Mar. 2024) data.
In the article Joining The Dark Side: Pirates, Spies and Short Sellers, James Montier reported that In their US sample covering the period 1968-2003, Cooper et al find that firms with low asset growth outperformed firms with high asset growth by an astounding 20% p.a. equally weighted. Even when controlling for market, size and style, low asset growth firms outperformed high asset growth firms by 13% p.a. Therefore a company with fast asset growth may underperform.
Total Assets is linked to total revenue through Asset Turnover.
Ocular Therapeutix's Asset Turnover for the quarter that ended in Mar. 2024 is
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Therefore, if a company grows its Total Assets faster than its Revenue, the Asset Turnover will decline. This might be a warning sign for the business.
Ocular Therapeutix Total Assets Related Terms
Thank you for viewing the detailed overview of Ocular Therapeutix's Total Assets provided by GuruFocus.com. Please click on the following links to see related term pages.
Ocular Therapeutix (Ocular Therapeutix) Business Description
Ocular Therapeutix Inc is a biotechnology company that specializes in therapies for diseases and conditions of the eye. The company uses its proprietary hydrogel platform technology to deliver therapeutic agents to the eye. Its pipeline consists of eye medication that aims to overcome the limitations of current eye-drop-based therapies for ophthalmic diseases and conditions. Ocular Therapeutix aims to offer medication to replace the existing eye-drop therapy regimen, with the aim of lasting weeks or months with a one-time product application. Its pipeline product includes Dextenza, OTX-TIC, OTX-TKI, and OTX-IVT.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
OCUL has been successfully added to your 